Andrew P Mazar

Summary

Affiliation: Northwestern University
Country: USA

Publications

  1. ncbi Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic
    Andrew P Mazar
    Molecular Biosciences, Northwestern University, Evanston, IL 60208, USA
    Curr Pharm Des 17:1970-8. 2011

Detail Information

Publications1

  1. ncbi Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic
    Andrew P Mazar
    Molecular Biosciences, Northwestern University, Evanston, IL 60208, USA
    Curr Pharm Des 17:1970-8. 2011
    ..This review will discuss some of the pitfalls that have delayed progress on uPAR-targeted interventions and will summarize recent progress in the development of uPAR-targeted therapeutics...